OpenAI's Bold Move: Revolutionizing Drug Development with AI Takeover after Orchestra Bio Acquisition!

OpenAI's Bold Move: Revolutionizing Drug Development with AI Takeover after Orchestra Bio Acquisition!

The ChatGPT maker is folding Orchestra’s drug-program agents into Rosalind, its life sciences suite, betting AI can shave time off the decade-plus it takes to bring a medicine to patients.

This article was originally published by Decrypt. Click through to read the complete story. The ChatGPT maker is folding Orchestra’s drug-program agents into Rosalind, its life sciences suite, betting AI can shave time off the decade-plus it takes to bring a medicine to patients.

Category: technology

Related Crypto News

Explore Crypto-Friendly Businesses